“发现青蒿琥酯（ARS） PROTACs作为GPX4蛋白降解剂用于治疗膀胱癌”的勘误表[欧洲]。医学化学。293 (2025)117710]

IF 5.9 2区医学 Q1 CHEMISTRY, MEDICINAL

European Journal of Medicinal Chemistry Pub Date : 2025-09-10 DOI:10.1016/j.ejmech.2025.118140

Xiyue Yang, Linghui Wang, Peiyu Lin, Yueni Ning, Yusi Lin, Yingying Xie, Congke Zhao, Lingli Mu, Cangcang Xu

引用次数: 0

摘要

没有抽象的

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Corrigendum to “Discovery of Artesunate (ARS) PROTACs as GPX4 protein degraders for the treatment of bladder cancer” [Eur. J. Med. Chem. 293 (2025) 117710]

No Abstract

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

European Journal of Medicinal Chemistry 化学-医药化学

CiteScore

11.70

自引率

9.00%

发文量

863

审稿时长

29 days

期刊介绍： The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers. A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.